Trial intelligence / Profile preview

CZ1S for postoperative analgesia in total knee arthroplasty

CTR20233395Phase 2Completed

Sponsor
Cuize Pharmaceutical
Start
Oct 2023
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of CZ1S in postoperative pain, sponsored by Cuize Pharmaceutical. Started Oct 2023; status: completed.

02

Drugs

CZ1S
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20233395.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20233395.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call